Aller au contenu principal
Profil bibliographique

Silvia Ancona

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

50Publications signalées
382Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Tuberous Sclerosis Complex ResearchVascular Tumors and AngiosarcomasEosinophilic Disorders and SyndromesRenal and related cancersGut microbiota and health

Les publications récentes

Accès ouvert 2026 preprint OpenAlex

Identification of ICAM-1–targeting DNA aptamers as a host-directed strategy to inhibit Human Rhinovirus infection

Jessica Dellavedova, Chiara Campera, Silvia Ancona, Monica Rebecchi et autres

Abstract Exacerbations of respiratory viral infections significantly contribute to morbidity and healthcare burden. Among these viruses, Human Rhinoviruses (HRVs) are the most frequent causative agents of upper respiratory tract infections. To date, over 150 HRV serotypes have been identified, classified into three …

it, us (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2026 article OpenAlex

Roseburia-Associated Gut–Brain Axis Alterations in Relapsing–Remitting Multiple Sclerosis: Evidence from a Household-Matched Case–Control Study

Alen Zollo, Matteo Domenico Marsiglia, Andrea Corona, Emerenziana Ottaviano et autres

Background/Objectives: Gut microbiota (GM) dysbiosis has been implicated in multiple sclerosis (MS) pathogenesis, influencing inflammation and neurodegeneration, but findings remain inconsistent due to environmental and methodological variability. This study aimed to identify possible microbial biomarkers of MS status and disease severity by …

it, us (code pays fourni par la source)

0 citations Nutrients
Accès ouvert 2026 erratum OpenAlex

Correction: Gut microbiota signatures in tuberous sclerosis complex and epilepsy: a pilot study

Emerenziana Ottaviano, Matteo Domenico Marsiglia, Camilla Ceccarani, Silvia Ancona et autres

A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval.• Please read through all the templates before choosing • Pick the most relevant text …

it, us (code pays fourni par la source)

0 citations Frontiers in Neuroscience
Accès ouvert 2025 article OpenAlex

Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study

Martina Tosi, Matteo Domenico Marsiglia, Emerenziana Ottaviano, Sara Parolisi et autres

Background/Objectives: Phenylketonuria (PKU) is an inherited metabolic disorder requiring early and lifelong dietary management through a low-phenylalanine (Phe) diet supplemented with Phe-free protein substitutes (PS). Recently developed slow-release PS formulations aim to mimic natural protein absorption, enhancing metabolic stability and tolerability. The …

it, us (code pays fourni par la source)

2 citations Nutrients
Accès ouvert 2025 article OpenAlex

Gut microbiota signatures in tuberous sclerosis complex and epilepsy: a pilot study

Emerenziana Ottaviano, Matteo Domenico Marsiglia, Camilla Ceccarani, Silvia Ancona et autres

Objective Tuberous sclerosis complex (TSC) presents with a broad clinical spectrum. While some individuals exhibit mild symptoms, most experience seizures and neuropsychiatric comorbidities. Emerging evidence suggests that both genetic and environmental factors, including gut microbiota, may influence epilepsy susceptibility. The microbiota–gut–brain axis …

it, us (code pays fourni par la source)

3 citations Frontiers in Neuroscience
Accès ouvert 2025 article OpenAlex

p300 inhibition delays premature cellular senescence

Elisabetta Di Fede, Esi Taci, Silvia Castiglioni, Stefano Rebellato et autres

Cellular senescence represents a permanent state of cell cycle arrest, also observed in neurodegenerative disorders. As p300 has been identified as an epigenetic driver of replicative senescence, we aimed to investigate whether in vitro p300 inhibition could rescue the stress-induced premature senescence …

it, us (code pays fourni par la source)

5 citations npj Aging
Accès ouvert 2025 article OpenAlex

Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients

Matteo Domenico Marsiglia, Silvia Bianchi, Francesca Bai, Camilla Tincati et autres

BACKGROUND: Anti-SARS-CoV-2 neutralizing monoclonal antibodies (mAbs) have been shown to have clinical benefits in treating high-risk patients with mild-moderate COVID-19. SARS-CoV-2 RNA in serum (RNAemia), is usually associated with severe disease and deaths. This study evaluates real-life data on the effectiveness of …

it, us (code pays fourni par la source)

1 citation PLoS ONE
Accès ouvert 2025 article OpenAlex

Pilocarpine inhibits Candida albicans SC5314 biofilm maturation by altering lipid, sphingolipid, and protein content

Emerenziana Ottaviano, Michele Dei, Silvia Ancona, Francesca Triva et autres

ABSTRACT Candida albicans filamentation and biofilm formation are key virulence factors tied to tissue invasion and antifungal tolerance. Pilocarpine hydrochloride (PHCl), a muscarinic receptor agonist, inhibits biofilm maturation, although its mechanism remains unclear. We explored PHCl effects by analyzing sphingolipid and lipid …

it (code pays fourni par la source)

2 citations Microbiology Spectrum
Accès ouvert 2024 article OpenAlex

Expanding the clinical spectrum of PPP3CA variants - alternative isoforms matter

Silvia Castiglioni, Laura Pezzoli, Lidia Pezzani, Antonella Lettieri et autres

BACKGROUND: the protein phosphatase 3 catalytic subunit alpha (PPP3CA) gene encodes for the alpha isoform of the calcineurin catalytic subunit, which controls the phosphorylation status of many targets. Currently, 23 pathogenic variants of PPP3CA are known, with clinical manifestations varying by mutation …

it (code pays fourni par la source)

4 citations Orphanet Journal of Rare Diseases
Accès ouvert 2024 article OpenAlex

Dysfunction in IGF2R Pathway and Associated Perturbations in Autophagy and WNT Processes in Beckwith–Wiedemann Syndrome Cell Lines

Silvana Pileggi, Elisa Adele Colombo, Silvia Ancona, Roberto Quadri et autres

upregulation in BWS, focusing on insulin-like growth factor pathways, which are poorly known in this syndrome. We examined the IGF2R, the primary receptor of IGF2, WNT, and autophagy/lysosomal pathways in BWS patient-derived lymphoblastoid cell lines, showing different genetic and epigenetic defects. The …

it (code pays fourni par la source)

3 citations International Journal of Molecular Sciences

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.